These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2880070)

  • 1. Immunoregulation and prognosis in myeloma.
    Joshua DE; Wearne A; Kronenberg H
    Lancet; 1987 Jan; 1(8527):251-3. PubMed ID: 2880070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
    Wearne A; Joshua DE; Kronenberg H
    Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression?
    King MA; Radicchi MA
    Br J Haematol; 1992 Jun; 81(2):218-22. PubMed ID: 1379466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma: light chain isotype suppression--a marker of stable disease at presentation.
    Wearne AJ; Joshua DE; Young GA; Kronenberg H
    Eur J Haematol; 1987 Jan; 38(1):43-9. PubMed ID: 3108026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
    Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
    Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: the relationship between CALLA (CD10) positive lymphocytes in the peripheral blood and light chain isotype suppression.
    Wearne AJ; Joshua DE; Brown RD; Kronenberg H
    Br J Haematol; 1987 Sep; 67(1):39-44. PubMed ID: 2959309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
    Nelson M; Brown RD; Gibson J; Joshua DE
    Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
    Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
    Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin isotypes on monoclonal blood lymphocytes in human plasma cell myeloma.
    Pettersson D; Mellstedt H; Holm G
    J Clin Lab Immunol; 1980 Mar; 3(2):93-8. PubMed ID: 6782249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-chain isotype-associated B cell suppression in multiple myeloma.
    Leonard RC
    Lancet; 1987 Apr; 1(8538):916. PubMed ID: 2882310
    [No Abstract]   [Full Text] [Related]  

  • 13. Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults.
    Briault S; Courtois-Capella M; Duarte F; Aucouturier P; Preud'Homme JL
    Clin Exp Immunol; 1988 Nov; 74(2):182-4. PubMed ID: 3147151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of kappa and lambda light chain isotypes among human blood immunoglobulin-secreting cells after vaccination with pneumococcal polysaccharides.
    Heilmann C; Barington T
    Scand J Immunol; 1989 Feb; 29(2):159-64. PubMed ID: 2493676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
    Papadea C; Reimer CB; Check IJ
    Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.
    Chen Y; Bhoopalam N; Yakulis V; Heller P
    Ann Intern Med; 1975 Nov; 83(5):625-31. PubMed ID: 812401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.